Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4489744 | 1.00 | — | — | |
| Hydrazine SCHEMBL28088113 | 0.96 | — | — | |
| SCHEMBL64716 | 0.95 | — | — | |
| SCHEMBL20178517 | 0.95 | NFKB1 (0.54) | — | |
| SCHEMBL10623380 | 0.95 | NFKB1 (0.54) | — | |
| SCHEMBL8014825 | 0.91 | — | — | |
| Potassium SCHEMBL18585217 | 0.91 | — | — | |
| SCHEMBL8017494 | 0.91 | — | — | |
| SCHEMBL1537923 | 0.91 | — | — | |
| Water SCHEMBL7464138 | 0.91 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260130040-A1 | ON-DEMAND FORMATION OF LEWIS BASE MOLECULES FOR EFFICIENT AND STABLE PEROVSKITE SOLAR CELLS | UNIV TOLEDO (US) | 2026-05-07 | — | — | US | claimed |
| CN-106032577-B | Restrainer composition and its application and the method that pickling is carried out to equipment | 中国石油化工股份有限公司 | 2018-11-02 | — | — | CN | claimed |
| EP-4711368-A1 | AZEPINE COMPOUND, AND COMPOSITION AND USE THEREOF | CHENGDU MFS PHARMA. CO., LTD. (CN) | 2026-03-18 | — | — | EP | disclosed |
| CN-117551046-B | Diamino urea HSL inhibitor, preparation method and application thereof | 广东药科大学附属第一医院 | 2025-10-28 | — | — | CN | disclosed |
| CN-117551046-A | Diamino urea HSL inhibitor, preparation method and application thereof | 广东药科大学附属第一医院 | 2024-02-13 | — | — | CN | disclosed |
| CN-117551046-A | Diamino urea HSL inhibitor, preparation method and application thereof | 广东药科大学附属第一医院 | 2024-02-13 | — | — | CN | disclosed |
| US-10150760-B2 | Compounds for use in preparing heterocyclic triazole agonists of the APJ receptor | AMGEN INC. (US) | 2018-12-11 | — | — | US | disclosed |
| CN-106032577-B | Restrainer composition and its application and the method that pickling is carried out to equipment | 中国石油化工股份有限公司 | 2018-11-02 | — | — | CN | disclosed |
| CN-106032576-B | Restrainer composition and its application and the method that pickling is carried out to equipment | 中国石油化工股份有限公司 | 2018-11-02 | — | — | CN | disclosed |
| US-20180222895-A1 | COMPOUNDS FOR USE IN PREPARING HETEROCYCLIC TRIAZOLE AGONISTS OF THE APJ RECEPTOR | AMGEN INC. | 2018-08-09 | — | — | US | disclosed |
| US-9988369-B2 | Heterocyclic triazole compounds as agonists of the APJ receptor | AMGEN INC. (US) | 2018-06-05 | — | — | US | disclosed |
| CN-104513998-A | Corrosion inhibitor composition, applications thereof, and method using same to perform acid-washing on equipment | CHINA PETROLEUM & CHEMICAL | 2015-04-15 | — | — | CN | disclosed |
| CN-104513992-A | Corrosion inhibitor composition, applications thereof, and method using same to perform acid-washing on equipment | CHINA PETROLEUM & CHEMICAL | 2015-04-15 | — | — | CN | disclosed |
| US-6960601-B2 | Preparation and use of imidazole derivatives for treatment of obesity | BAYER PHARMACEUTICALS CORPORATION (US) | 2005-11-01 | — | — | US | disclosed |
| US-6831039-B1 | Herbicides with high crop plants compatibility | BASF AKTIENGESELLSCHAFT (DE) | 2004-12-14 | — | — | US | disclosed |
| US-6506708-B1 | Herbicidal activity of the 3-(heterocyclyl)benzoylpyrazole derivatives of the formula I was demonstrated | BASF AKTIENGESELLSCHAFT (DE) | 2003-01-14 | — | — | US | disclosed |
| CN-1057520-C | N,N'-substituted imidodicarbonimidic diamides derived from hydroxylamines | JACOBUS PHARMA CO INC (US) | 2000-10-18 | — | — | CN | disclosed |
| CN-1053176-C | Process for preparation of 1,2-and 1,3-pronpandiol | DEGUSSA (DE) | 2000-06-07 | — | — | CN | disclosed |
| CN-1090568-A | Preparation 1,2-propylene glycol and 1, the method for ammediol | DEGUSSA (DE) | 1994-08-10 | — | — | CN | disclosed |
| CN-1076689-A | From oxyamine deutero-N, N '-'-substituted imidodicarbonimidic diamides | JACOBUS PHARMA CO INC (US) | 1993-09-29 | — | — | CN | disclosed |